• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099

Professional Introduction to Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate (CAS No. 163210-23-9)

Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate, a compound with the chemical formula C??H??INO, is a significant molecule in the field of pharmaceutical research and development. This compound has garnered attention due to its structural properties and potential applications in drug design. The presence of a piperidine ring and an iodine substituent makes it a valuable intermediate in synthesizing various bioactive molecules. The CAS No. 163210-23-9 provides a unique identifier for this compound, ensuring precise recognition and documentation in scientific literature and industrial applications.

The structure of Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate features a tert-butyl group attached to the carboxylate moiety, while the piperidine ring is linked to a 3-iodopropyl side chain. This configuration imparts specific electronic and steric properties that are highly relevant in medicinal chemistry. The iodine atom, in particular, serves as a handle for further functionalization through cross-coupling reactions, such as Suzuki-Miyaura or Stille couplings, which are widely employed in the synthesis of complex organic molecules.

In recent years, there has been a surge in research focused on developing novel therapeutic agents targeting neurological disorders. Piperidine derivatives have shown promise in this area due to their ability to interact with various neurotransmitter receptors. The Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate molecule, with its unique structural features, could serve as a key intermediate in the synthesis of potential neuropharmacological agents. For instance, its scaffold can be modified to develop ligands that modulate serotonin or dopamine receptors, which are implicated in conditions such as depression, anxiety, and Parkinson's disease.

Advances in computational chemistry have also facilitated the design of molecules like Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate with enhanced binding affinity and selectivity. Molecular docking studies have demonstrated that this compound can interact with specific protein targets, making it a candidate for structure-based drug design. The combination of experimental synthesis and computational modeling has accelerated the discovery process in pharmaceutical research. This interdisciplinary approach has led to the identification of novel compounds with therapeutic potential.

The synthesis of Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate involves multi-step organic reactions that require precise control over reaction conditions. The introduction of the iodine substituent at the propyl chain enhances reactivity, enabling further derivatization. Researchers have explored various synthetic pathways to optimize yield and purity. For example, nucleophilic substitution reactions followed by protection-deprotection strategies have been employed to introduce the desired functional groups efficiently.

Recent studies have highlighted the importance of fluorinated and halogenated piperidine derivatives in medicinal chemistry. The iodine atom in Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate not only facilitates cross-coupling reactions but also influences the pharmacokinetic properties of derived compounds. Halogen atoms are known to enhance metabolic stability and binding affinity, making them crucial for drug development. The incorporation of iodine into piperidine-based scaffolds has opened new avenues for designing more effective pharmaceuticals.

The pharmacological evaluation of Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate and its derivatives is an ongoing area of research. Preclinical studies have begun to explore its potential as a tool compound for investigating receptor mechanisms and developing novel therapeutics. The compound's ability to modulate neurotransmitter systems makes it particularly interesting for studying neurological disorders. Additionally, its structural flexibility allows for modifications that could improve solubility, bioavailability, and target specificity.

In conclusion, Tert-butyl 3-(3-iodopropyl)piperidine-1-carboxylate (CAS No. 163210-23-9) is a versatile compound with significant implications in pharmaceutical research. Its unique structural features and reactivity make it a valuable intermediate for synthesizing bioactive molecules targeting neurological disorders. The combination of experimental synthesis, computational modeling, and pharmacological evaluation continues to drive advancements in drug discovery. As research progresses, this compound is expected to play a crucial role in developing next-generation therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)